NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1752645431|gb|KAA9224537|]
View 

acinetobactin non-ribosomal peptide synthetase subunit BasB [Acinetobacter baumannii]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
C_NRPS-like super family cl40425
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ...
256-557 3.45e-54

Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


The actual alignment was detected with superfamily member cd19540:

Pssm-ID: 394795 [Multi-domain]  Cd Length: 433  Bit Score: 191.87  E-value: 3.45e-54
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWqaysafdF-------SPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSE 328
Cdd:cd19540     3 PLSFAQQRLW-------FlnrldgpSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLPAAE 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 329 LQ-QFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNA 407
Cdd:cd19540    76 ARpDLTVVDVTEDELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAG 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 408 QAPNWKAPAQSILDFSLLQQKQ-GINQD-------HLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLELK 474
Cdd:cd19540   156 RAPDWAPLPVQYADYALWQRELlGDEDDpdslaarQLAYWRETLAGLPEELELP-------TDRPRPAVAsyrggTVEFT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 475 FAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQS 554
Cdd:cd19540   229 IDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAE 308

                  ...
gi 1752645431 555 LLH 557
Cdd:cd19540   309 LLA 311
PP-binding pfam00550
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ...
169-232 3.99e-08

Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.


:

Pssm-ID: 425746 [Multi-domain]  Cd Length: 62  Bit Score: 50.25  E-value: 3.99e-08
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1752645431 169 NYVSEIILEEFRntLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAAD 232
Cdd:pfam00550   1 ERLRELLAEVLG--VPAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
 
Name Accession Description Interval E-value
LCL_NRPS-like cd19540
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ...
256-557 3.45e-54

LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.


Pssm-ID: 380463 [Multi-domain]  Cd Length: 433  Bit Score: 191.87  E-value: 3.45e-54
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWqaysafdF-------SPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSE 328
Cdd:cd19540     3 PLSFAQQRLW-------FlnrldgpSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLPAAE 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 329 LQ-QFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNA 407
Cdd:cd19540    76 ARpDLTVVDVTEDELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAG 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 408 QAPNWKAPAQSILDFSLLQQKQ-GINQD-------HLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLELK 474
Cdd:cd19540   156 RAPDWAPLPVQYADYALWQRELlGDEDDpdslaarQLAYWRETLAGLPEELELP-------TDRPRPAVAsyrggTVEFT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 475 FAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQS 554
Cdd:cd19540   229 IDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAE 308

                  ...
gi 1752645431 555 LLH 557
Cdd:cd19540   309 LLA 311
Condensation pfam00668
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ...
253-676 8.32e-47

Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.


Pssm-ID: 395541 [Multi-domain]  Cd Length: 454  Bit Score: 172.13  E-value: 8.32e-47
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 253 DQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIptSELQQF 332
Cdd:pfam00668   3 DEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVI--LEERPF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 333 KWF-----WNSAESKDATLASEA----SYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLA 403
Cdd:pfam00668  81 ELEiidisDLSESEEEEAIEAFIqrdlQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQ 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 404 -RSNAQAPNwkAPAQSILDF-----SLLQQKQgiNQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQWLE----- 472
Cdd:pfam00668 161 lLKGEPLPL--PPKTPYKDYaewlqQYLQSED--YQKDAAYWLEQLEGELPVLQLP-------KDYARPADRSFKgdrls 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 473 LKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSF 552
Cdd:pfam00668 230 FTLDEDTEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTF 309
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 553 QSLLHNISTMINTSMAYADIPINHIQNALGMRADEGL--LFDVFIHIHSNNALNGALKTPQGQNLPYRQILPERDESMFG 630
Cdd:pfam00668 310 SELIKRVQEDLLSAEPHQGYPFGDLVNDLRLPRDLSRhpLFDPMFSFQNYLGQDSQEEEFQLSELDLSVSSVIEEEAKYD 389
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*.
gi 1752645431 631 LHFEIMEnvIDGqhQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:pfam00668 390 LSLTASE--RGG--GLTIKIDYNTSLFDEETIERFAEHFKELLEQA 431
PRK05691 PRK05691
peptide synthase; Validated
152-676 1.15e-45

peptide synthase; Validated


Pssm-ID: 235564 [Multi-domain]  Cd Length: 4334  Bit Score: 176.13  E-value: 1.15e-45
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  152 SNQLDANSTKASEQSNQNYVSEIileeFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSP--- 228
Cdd:PRK05691   572 LQAVEAAQTAASGDELQARIAAI----WCEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLRQLFEAPtla 647
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  229 --SAADLAQYALVKSAKTEKTTLQSVDQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHA 306
Cdd:PRK05691   648 afSAAVARQLAGGGAAQAAIARLPRGQALPQSLAQNRLWLLWQLDPQSAAYNIPGGLHLRGELDEAALRASFQRLVERHE 727
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  307 GLRTIFNSANGQTYQQVIPTSE--LQQFKWFWNSAESKDATLAS----EASYKFDLTRELPLRIRLIRNAKGRQTLSFLV 380
Cdd:PRK05691   728 SLRTRFYERDGVALQRIDAQGEfaLQRIDLSDLPEAEREARAAQireeEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTL 807
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  381 HHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSLLQQK---QGINQDHLNYWTNLLRGATKGLNLPvSEH 457
Cdd:PRK05691   808 HHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPLGYADYGAWQRQwlaQGEAARQLAYWKAQLGDEQPVLELA-TDH 886
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  458 ELNAEKEKPPVQwLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFT 537
Cdd:PRK05691   887 PRSARQAHSAAR-YSLRVDASLSEALRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPRLETQGLVGFFI 965
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  538 TMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGmRADEGLLFDVFIHiHSNNALNGALKTPQ--GQNL 615
Cdd:PRK05691   966 NTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALP-QAREQGLFQVMFN-HQQRDLSALRRLPGllAEEL 1043
                          490       500       510       520       530       540
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1752645431  616 PYRQilperDESMFGLHFEIMEnviDGQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:PRK05691  1044 PWHS-----REAKFDLQLHSEE---DRNGRLTLSFDYAAELFDAATIERLAEHFLALLEQV 1096
EntF COG1020
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ...
248-676 1.62e-44

EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 440643 [Multi-domain]  Cd Length: 1329  Bit Score: 171.96  E-value: 1.62e-44
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  248 TLQSVDQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPT- 326
Cdd:COG1020     11 PAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQPVv 90
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  327 -----SELQQFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAY 401
Cdd:COG1020     91 aaplpVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELLRLY 170
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  402 LARSNAQAPNWKAPAQSILDFSLLQQKQ---GINQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLEL 473
Cdd:COG1020    171 LAAYAGAPLPLPPLPIQYADYALWQREWlqgEELARQLAYWRQQLAGLPPLLELP-------TDRPRPAVQsyrgaRVSF 243
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  474 KFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQ 553
Cdd:COG1020    244 RLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGDPSFA 323
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  554 SLLHNISTMINTSMAYADIPINHIQNALGMRADEGL--LFDVFIhihsnNALNGALKTPQGQNLPYRQILPERDESMFGL 631
Cdd:COG1020    324 ELLARVRETLLAAYAHQDLPFERLVEELQPERDLSRnpLFQVMF-----VLQNAPADELELPGLTLEPLELDSGTAKFDL 398
                          410       420       430       440
                   ....*....|....*....|....*....|....*....|....*
gi 1752645431  632 HFEIMENvidgQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:COG1020    399 TLTVVET----GDGLRLTLEYNTDLFDAATIERMAGHLVTLLEAL 439
PP-binding pfam00550
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ...
169-232 3.99e-08

Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.


Pssm-ID: 425746 [Multi-domain]  Cd Length: 62  Bit Score: 50.25  E-value: 3.99e-08
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1752645431 169 NYVSEIILEEFRntLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAAD 232
Cdd:pfam00550   1 ERLRELLAEVLG--VPAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
AcpP COG0236
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ...
162-236 1.36e-07

Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis


Pssm-ID: 440006 [Multi-domain]  Cd Length: 80  Bit Score: 49.47  E-value: 1.36e-07
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1752645431 162 ASEQSNQNYVSEIILEEFRntLAEPEMSQHDDFF-DFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQY 236
Cdd:COG0236     1 MPREELEERLAEIIAEVLG--VDPEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADY 74
alpha_am_amid TIGR03443
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ...
168-234 1.08e-06

L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.


Pssm-ID: 274582 [Multi-domain]  Cd Length: 1389  Bit Score: 52.37  E-value: 1.08e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  168 QNYVSEIILEEFRNTLAE-------------PEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLA 234
Cdd:TIGR03443  835 KNRSASAADEEFTETEREirdlwlellpnrpATISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFA 914
PRK12316 PRK12316
peptide synthase; Provisional
179-237 8.83e-06

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 49.57  E-value: 8.83e-06
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|....*....
gi 1752645431  179 FRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQYA 237
Cdd:PRK12316  5081 WAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELA 5139
PKS_PP smart00823
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ...
194-236 9.29e-03

Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.


Pssm-ID: 214834 [Multi-domain]  Cd Length: 86  Bit Score: 35.69  E-value: 9.29e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....
gi 1752645431  194 FFDFGGHSLLATRIIgNLLNKH-GIEIQFNDFFKSPSAADLAQY 236
Cdd:smart00823  39 FRDLGLDSLMAVELR-NRLEAAtGLRLPATLVFDHPTPAALAEH 81
 
Name Accession Description Interval E-value
LCL_NRPS-like cd19540
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ...
256-557 3.45e-54

LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.


Pssm-ID: 380463 [Multi-domain]  Cd Length: 433  Bit Score: 191.87  E-value: 3.45e-54
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWqaysafdF-------SPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSE 328
Cdd:cd19540     3 PLSFAQQRLW-------FlnrldgpSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLPAAE 75
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 329 LQ-QFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNA 407
Cdd:cd19540    76 ARpDLTVVDVTEDELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAG 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 408 QAPNWKAPAQSILDFSLLQQKQ-GINQD-------HLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLELK 474
Cdd:cd19540   156 RAPDWAPLPVQYADYALWQRELlGDEDDpdslaarQLAYWRETLAGLPEELELP-------TDRPRPAVAsyrggTVEFT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 475 FAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQS 554
Cdd:cd19540   229 IDAELHARLAALAREHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAE 308

                  ...
gi 1752645431 555 LLH 557
Cdd:cd19540   309 LLA 311
LCL_NRPS cd19538
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ...
254-581 2.63e-52

LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.


Pssm-ID: 380461 [Multi-domain]  Cd Length: 432  Bit Score: 186.70  E-value: 2.63e-52
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 254 QAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSE----L 329
Cdd:cd19538     1 EIPLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEEDGVPYQLILEEDEatpkL 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 330 QQFKwfwNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQA 409
Cdd:cd19538    81 EIKE---VDEEELESEINEAVRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKGEA 157
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 410 PNWKAPAQSILDFSLLQQKQG--------INQDHLNYWTNLLRGATKGLNLPVSEHELNAEKEKPPVQWLELKfaPEMHE 481
Cdd:cd19538   158 PELAPLPVQYADYALWQQELLgdesdpdsLIARQLAYWKKQLAGLPDEIELPTDYPRPAESSYEGGTLTFEID--SELHQ 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 482 KLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNIST 561
Cdd:cd19538   236 QLLQLAKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKE 315
                         330       340
                  ....*....|....*....|
gi 1752645431 562 MINTSMAYADIPINHIQNAL 581
Cdd:cd19538   316 TNLEAYEHQDIPFERLVEAL 335
LCL_NRPS-like cd19531
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ...
255-663 2.21e-49

LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.


Pssm-ID: 380454 [Multi-domain]  Cd Length: 427  Bit Score: 178.32  E-value: 2.21e-49
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 255 APLTLAQD---FLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQ- 330
Cdd:cd19531     2 LPLSFAQQrlwFLDQLEPG---SAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDGEPVQVILPPLPLPl 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 331 -----QFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARS 405
Cdd:cd19531    79 pvvdlSGLPEAEREAEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFL 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 406 NAQAPNWKAPAQSILDFSLLQQKQ---GINQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLELKFAP 477
Cdd:cd19531   159 AGRPSPLPPLPIQYADYAVWQREWlqgEVLERQLAYWREQLAGAPPVLELP-------TDRPRPAVQsfrgaRVRFTLPA 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 478 EMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLH 557
Cdd:cd19531   232 ELTAALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLA 311
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 558 NISTMINTSMAYADIPINHIQNALGMRADegL----LFDV-FIHihsNNALNGALKTPqgqNLPYRQILPERDESMFGLH 632
Cdd:cd19531   312 RVRETALEAYAHQDLPFEKLVEALQPERD--LsrspLFQVmFVL---QNAPAAALELP---GLTVEPLEVDSGTAKFDLT 383
                         410       420       430
                  ....*....|....*....|....*....|.
gi 1752645431 633 FEIMEnvidGQHQLSMIITYQAHRFPTATVQ 663
Cdd:cd19531   384 LSLTE----TDGGLRGSLEYNTDLFDAATIE 410
SgcC5_NRPS-like cd19539
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ...
255-675 2.56e-48

SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380462 [Multi-domain]  Cd Length: 427  Bit Score: 175.65  E-value: 2.56e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 255 APLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIF-NSANGQTYQQVIPTS----EL 329
Cdd:cd19539     2 IPLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLvRDDGGVPRQEILPPGpaplEV 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 330 QQFKWFWNSAESKDATLASEA-SYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQ 408
Cdd:cd19539    82 RDLSDPDSDRERRLEELLREReSRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKGP 161
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 409 APNWKAPAQSILDFSLLQQKQ-GINQ--DHLNYWTNLLRGA---TKGLNLPVSeHELNAekekpPVQWLELKFAPEMHEK 482
Cdd:cd19539   162 AAPLPELRQQYKEYAAWQREAlAAPRaaELLDFWRRRLRGAeptALPTDRPRP-AGFPY-----PGADLRFELDAELVAA 235
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 483 LLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTM 562
Cdd:cd19539   236 LRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRKA 315
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 563 INTSMAYADIPINHIQNALGMRADEGLLFDVFIHIHSNNALNGALKTPQGqnLPYRQILPERDESMFGLHFEIMENVIDg 642
Cdd:cd19539   316 LVDAQRHQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNAPAGELELAGG--LSYTEGSDIPDGAKFDLNLTVTEEGTG- 392
                         410       420       430
                  ....*....|....*....|....*....|...
gi 1752645431 643 qhqLSMIITYQAHRFPTATVQSICEKIKATLAQ 675
Cdd:cd19539   393 ---LRGSLGYATSLFDEETIQGFLADYLQVLRQ 422
Condensation pfam00668
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ...
253-676 8.32e-47

Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.


Pssm-ID: 395541 [Multi-domain]  Cd Length: 454  Bit Score: 172.13  E-value: 8.32e-47
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 253 DQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIptSELQQF 332
Cdd:pfam00668   3 DEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIRQENGEPVQVI--LEERPF 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 333 KWF-----WNSAESKDATLASEA----SYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLA 403
Cdd:pfam00668  81 ELEiidisDLSESEEEEAIEAFIqrdlQSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQ 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 404 -RSNAQAPNwkAPAQSILDF-----SLLQQKQgiNQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQWLE----- 472
Cdd:pfam00668 161 lLKGEPLPL--PPKTPYKDYaewlqQYLQSED--YQKDAAYWLEQLEGELPVLQLP-------KDYARPADRSFKgdrls 229
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 473 LKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSF 552
Cdd:pfam00668 230 FTLDEDTEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTF 309
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 553 QSLLHNISTMINTSMAYADIPINHIQNALGMRADEGL--LFDVFIHIHSNNALNGALKTPQGQNLPYRQILPERDESMFG 630
Cdd:pfam00668 310 SELIKRVQEDLLSAEPHQGYPFGDLVNDLRLPRDLSRhpLFDPMFSFQNYLGQDSQEEEFQLSELDLSVSSVIEEEAKYD 389
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*.
gi 1752645431 631 LHFEIMEnvIDGqhQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:pfam00668 390 LSLTASE--RGG--GLTIKIDYNTSLFDEETIERFAEHFKELLEQA 431
PRK05691 PRK05691
peptide synthase; Validated
152-676 1.15e-45

peptide synthase; Validated


Pssm-ID: 235564 [Multi-domain]  Cd Length: 4334  Bit Score: 176.13  E-value: 1.15e-45
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  152 SNQLDANSTKASEQSNQNYVSEIileeFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSP--- 228
Cdd:PRK05691   572 LQAVEAAQTAASGDELQARIAAI----WCEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLRQLFEAPtla 647
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  229 --SAADLAQYALVKSAKTEKTTLQSVDQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHA 306
Cdd:PRK05691   648 afSAAVARQLAGGGAAQAAIARLPRGQALPQSLAQNRLWLLWQLDPQSAAYNIPGGLHLRGELDEAALRASFQRLVERHE 727
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  307 GLRTIFNSANGQTYQQVIPTSE--LQQFKWFWNSAESKDATLAS----EASYKFDLTRELPLRIRLIRNAKGRQTLSFLV 380
Cdd:PRK05691   728 SLRTRFYERDGVALQRIDAQGEfaLQRIDLSDLPEAEREARAAQireeEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTL 807
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  381 HHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSLLQQK---QGINQDHLNYWTNLLRGATKGLNLPvSEH 457
Cdd:PRK05691   808 HHIVADGWSLNILLDEFSRLYAAACQGQTAELAPLPLGYADYGAWQRQwlaQGEAARQLAYWKAQLGDEQPVLELA-TDH 886
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  458 ELNAEKEKPPVQwLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFT 537
Cdd:PRK05691   887 PRSARQAHSAAR-YSLRVDASLSEALRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPRLETQGLVGFFI 965
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  538 TMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGmRADEGLLFDVFIHiHSNNALNGALKTPQ--GQNL 615
Cdd:PRK05691   966 NTQVLRAQLDGRLPFTALLAQVRQATLGAQAHQDLPFEQLVEALP-QAREQGLFQVMFN-HQQRDLSALRRLPGllAEEL 1043
                          490       500       510       520       530       540
                   ....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1752645431  616 PYRQilperDESMFGLHFEIMEnviDGQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:PRK05691  1044 PWHS-----REAKFDLQLHSEE---DRNGRLTLSFDYAAELFDAATIERLAEHFLALLEQV 1096
EntF COG1020
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ...
248-676 1.62e-44

EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 440643 [Multi-domain]  Cd Length: 1329  Bit Score: 171.96  E-value: 1.62e-44
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  248 TLQSVDQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPT- 326
Cdd:COG1020     11 PAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPVQVIQPVv 90
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  327 -----SELQQFKWFWNSAESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAY 401
Cdd:COG1020     91 aaplpVVVLLVDLEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLLAELLRLY 170
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  402 LARSNAQAPNWKAPAQSILDFSLLQQKQ---GINQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-----WLEL 473
Cdd:COG1020    171 LAAYAGAPLPLPPLPIQYADYALWQREWlqgEELARQLAYWRQQLAGLPPLLELP-------TDRPRPAVQsyrgaRVSF 243
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  474 KFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQ 553
Cdd:COG1020    244 RLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSGDPSFA 323
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  554 SLLHNISTMINTSMAYADIPINHIQNALGMRADEGL--LFDVFIhihsnNALNGALKTPQGQNLPYRQILPERDESMFGL 631
Cdd:COG1020    324 ELLARVRETLLAAYAHQDLPFERLVEELQPERDLSRnpLFQVMF-----VLQNAPADELELPGLTLEPLELDSGTAKFDL 398
                          410       420       430       440
                   ....*....|....*....|....*....|....*....|....*
gi 1752645431  632 HFEIMENvidgQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:COG1020    399 TLTVVET----GDGLRLTLEYNTDLFDAATIERMAGHLVTLLEAL 439
PRK12467 PRK12467
peptide synthase; Provisional
154-667 2.25e-44

peptide synthase; Provisional


Pssm-ID: 237108 [Multi-domain]  Cd Length: 3956  Bit Score: 172.27  E-value: 2.25e-44
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  154 QLDANSTKASEQSNQNYVSEIILEEFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADL 233
Cdd:PRK12467  1014 KPDASAVQATFVAPQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGF 1093
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  234 AQyALVKSAKTEKTTLQSVD-QAPLTL--AQD---FLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAG 307
Cdd:PRK12467  1094 AQ-AVAAQQQGAQPALPDVDrDQPLPLsyAQErqwFLWQLEPG---SAAYHIPQALRLKGPLDIEALERSFDALVARHES 1169
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  308 LRTIFNSANGQTYQQVIPTSELQQFKWFWNSAESKDATLAS----EASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHM 383
Cdd:PRK12467  1170 LRTTFVQEDGRTRQVIHPVGSLTLEEPLLLAADKDEAQLKVyveaEARQPFDLEQGPLLRVGLLRLAADEHVLVLTLHHI 1249
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  384 VIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSLLQQK---QGINQDHLNYWTNLLRGATKGLNLPvseheln 460
Cdd:PRK12467  1250 VSDGWSMQVLVDELVALYAAYSQGQSLQLPALPIQYADYAVWQRQwmdAGERARQLAYWKAQLGGEQPVLELP------- 1322
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  461 AEKEKPPVQ-----WLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGY 535
Cdd:PRK12467  1323 TDRPRPAVQshrgaRLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAETEGLIGF 1402
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  536 FTTMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALgmRADEGL----LFDV-FIHihsNNALNGALKTP 610
Cdd:PRK12467  1403 FVNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQDLPFEQLVEAL--QPERSLshspLFQVmFNH---QRDDHQAQAQL 1477
                          490       500       510       520       530
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 1752645431  611 QGQNLpyrQILPERDESMfglHFEIMENVIDGQHQLSMIITYQAHRFPTATVQSICE 667
Cdd:PRK12467  1478 PGLSV---ESLSWESQTA---QFDLTLDTYESSEGLQASLTYATDLFEASTIERLAG 1528
C_NRPS-like cd19066
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ...
256-676 1.11e-39

Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380453 [Multi-domain]  Cd Length: 427  Bit Score: 151.41  E-value: 1.11e-39
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQFkwf 335
Cdd:cd19066     3 PLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRYEQVVLDKTVRFRI--- 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 336 wnsaESKD--------ATLASE----ASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLA 403
Cdd:cd19066    80 ----EIIDlrnladpeARLLELidqiQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDA 155
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 404 RSNAQaPNWKAPAQSILDFSLLQQKQGINQDH---LNYWTNLLRGATKGLNLPvsehelnaeKEKPPVQ-----WLELKF 475
Cdd:cd19066   156 AERQK-PTLPPPVGSYADYAAWLEKQLESEAAqadLAYWTSYLHGLPPPLPLP---------KAKRPSQvasyeVLTLEF 225
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 476 A--PEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQ 553
Cdd:cd19066   226 FlrSEETKRLREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFP 305
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 554 SLLHNISTMINTSMAYADIPINHIQNALGMR--ADEGLLFDVFIHIHSNNALNGalkTPQGQNLPyRQILPERDESMFGL 631
Cdd:cd19066   306 ELLKRTKEQSREAIEHQRVPFIELVRHLGVVpeAPKHPLFEPVFTFKNNQQQLG---KTGGFIFT-TPVYTSSEGTVFDL 381
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*
gi 1752645431 632 HFEIMENVIDGqhqLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:cd19066   382 DLEASEDPDGD---LLLRLEYSRGVYDERTIDRFAERYMTALRQL 423
PRK12316 PRK12316
peptide synthase; Provisional
156-676 1.97e-39

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 157.04  E-value: 1.97e-39
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  156 DANSTKASEQSNQNYVSEIILEEFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAq 235
Cdd:PRK12316  2502 DVSQLRQAYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFA- 2580
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  236 yALVKSAKTEKT-TLQSVDQA---PLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTI 311
Cdd:PRK12316  2581 -ASLESGQTSRApVLQKVTRVqplPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTR 2659
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  312 FNSANGQTYQQVIPTSELQQF-KWFWNSAESK-DATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWS 389
Cdd:PRK12316  2660 FVEVGEQTRQVILPNMSLRIVlEDCAGVADAAiRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGWS 2739
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  390 LNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSLLQQ---KQGINQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKP 466
Cdd:PRK12316  2740 MQVMVDELVQAYAGARRGEQPTLPPLPLQYADYAAWQRawmDSGEGARQLDYWRERLGGEQPVLELP-------LDRPRP 2812
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  467 PVQ-----WLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVA 541
Cdd:PRK12316  2813 ALQshrgaRLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETERLIGFFVNTQV 2892
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  542 HRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGMRADEG--LLFDVFIhihsnNALNGALKTPQGQNLPYRQ 619
Cdd:PRK12316  2893 LRAQVDAQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLShsPLFQVMY-----NHQSGERAAAQLPGLHIES 2967
                          490       500       510       520       530
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 1752645431  620 ILPERDESMFGLHFEIMENVidgqHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:PRK12316  2968 FAWDGAATQFDLALDTWESA----EGLGASLTYATDLFDARTVERLARHWQNLLRGM 3020
COG4908 COG4908
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ...
257-495 2.06e-37

Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];


Pssm-ID: 443936 [Multi-domain]  Cd Length: 243  Bit Score: 139.79  E-value: 2.06e-37
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 257 LTLAQDFLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQqFKWFW 336
Cdd:COG4908     1 LSPAQKRFLFLEPG---SNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGEPVQRIDPDADLP-LEVVD 76
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 337 NSAESKDAT-------LASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQA 409
Cdd:COG4908    77 LSALPEPEReaeleelVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGEP 156
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 410 PNWKAPAQSILDFSLLQQKQ---GINQDHLNYWTNLLRGATKGLNLPVsehelnaEKEKPPVQ-----WLELKFAPEMHE 481
Cdd:COG4908   157 PPLPELPIQYADYAAWQRAWlqsEALEKQLEYWRQQLAGAPPVLELPT-------DRPRPAVQtfrgaTLSFTLPAELTE 229
                         250
                  ....*....|....
gi 1752645431 482 KLLAFSRQHSSSIF 495
Cdd:COG4908   230 ALKALAKAHGATVN 243
PRK05691 PRK05691
peptide synthase; Validated
179-581 4.27e-34

peptide synthase; Validated


Pssm-ID: 235564 [Multi-domain]  Cd Length: 4334  Bit Score: 140.30  E-value: 4.27e-34
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  179 FRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFK-SPSAADLAQYALVKSA--KTEKTTLQSVDQA 255
Cdd:PRK05691  1647 WREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEaSELGAFAEQVARIQAAgeRNSQGAIARVDRS 1726
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  256 ---PLTLAQD---FLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSEL 329
Cdd:PRK05691  1727 qpvPLSYSQQrmwFLWQMEPD---SPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSVDGVPVQQVAEDSGL 1803
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  330 qQFKWFWNSAESKDA------TLA-SEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYL 402
Cdd:PRK05691  1804 -RMDWQDFSALPADArqqrlqQLAdSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWAMDIFARELGALYE 1882
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  403 A----RSNAQAPnwkAPAQsILDFSLLQQK---QGINQDHLNYWTNLLRgatkglnlpvSEH---ELNAEKEKPPVQ--- 469
Cdd:PRK05691  1883 AflddRESPLEP---LPVQ-YLDYSVWQRQwleSGERQRQLDYWKAQLG----------NEHpllELPADRPRPPVQshr 1948
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  470 --WLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFS 547
Cdd:PRK05691  1949 geLYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVLRCQLD 2028
                          410       420       430
                   ....*....|....*....|....*....|....
gi 1752645431  548 PSDSFQSLLHNISTMINTSMAYADIPINHIQNAL 581
Cdd:PRK05691  2029 GQMSVSELLEQVRQTVIEGQSHQDLPFDHLVEAL 2062
PRK12467 PRK12467
peptide synthase; Provisional
252-676 8.32e-34

peptide synthase; Provisional


Pssm-ID: 237108 [Multi-domain]  Cd Length: 3956  Bit Score: 139.53  E-value: 8.32e-34
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  252 VDQAPLTLAQD---FLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSE 328
Cdd:PRK12467    47 FERIPLSYAQErqwFLWQLDPD---SAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDEEGFRQVIDASLS 123
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  329 LQ-QFKWFWNSAESKD-----ATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYL 402
Cdd:PRK12467   124 LTiPLDDLANEQGRAResqieAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEELVQLYS 203
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  403 ARSNAQAPnwKAPAQSI--LDFSLLQQ---KQGINQDHLNYWTNLLRGATKGLNLPVsehelnaEKEKPPVQ-----WLE 472
Cdd:PRK12467   204 AYSQGREP--SLPALPIqyADYAIWQRswlEAGERERQLAYWQEQLGGEHTVLELPT-------DRPRPAVPsyrgaRLR 274
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  473 LKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSF 552
Cdd:PRK12467   275 VDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQASF 354
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  553 QSLLHNISTMINTSMAYADIPINHIQNALGMRADEGL--LFDVFIHiHSNNAlnGALKTPQGQNLP---YRQILPERDES 627
Cdd:PRK12467   355 LELLQQVKRTALGAQAHQDLPFEQLVEALQPERSLSHspLFQVMFN-HQNTA--TGGRDREGAQLPgltVEELSWARHTA 431
                          410       420       430       440
                   ....*....|....*....|....*....|....*....|....*....
gi 1752645431  628 MFGLHFEIMENvidgQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:PRK12467   432 QFDLALDTYES----AQGLWAAFTYATDLFEATTIERLATHWRNLLEAI 476
CT_NRPS-like cd19542
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ...
277-676 1.74e-33

Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380464 [Multi-domain]  Cd Length: 401  Bit Score: 132.82  E-value: 1.74e-33
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 277 YNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIF--NSANGQTYQQViptseLQQFKWFWNSAESKDATLASEASYKF 354
Cdd:cd19542    22 YFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFveSSAEGTFLQVV-----LKSLDPPIEEVETDEDSLDALTRDLL 96
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 355 D---LTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQsildfSLLQQKQgi 431
Cdd:cd19542    97 DdptLFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNGQLLPPAPPFSDYIS-----YLQSQSQ-- 169
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 432 nQDHLNYWTNLLRGATkGLNLPVSEHELNAEKEKPPVQwlelkfapEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGN 511
Cdd:cd19542   170 -EESLQYWRKYLQGAS-PCAFPSLSPKRPAERSLSSTR--------RSLAKLEAFCASLGVTLASLFQAAWALVLARYTG 239
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 512 LKDIVIGTSASGRT--DPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGMRADeGL 589
Cdd:cd19542   240 SRDVVFGYVVSGRDlpVPGIDDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSLREIQRALGLWPS-GT 318
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 590 LFDVFIHIHSnnalngalKTPQGQNLPYRQILPERDESMFGLHFEIMENVIDGQHQLSMIITYQAHRFPTATVQSICEKI 669
Cdd:cd19542   319 LFNTLVSYQN--------FEASPESELSGSSVFELSAAEDPTEYPVAVEVEPSGDSLKVSLAYSTSVLSEEQAEELLEQF 390

                  ....*..
gi 1752645431 670 KATLAQI 676
Cdd:cd19542   391 DDILEAL 397
X-Domain_NRPS cd19546
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ...
253-676 2.16e-32

X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.


Pssm-ID: 380468 [Multi-domain]  Cd Length: 440  Bit Score: 130.29  E-value: 2.16e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 253 DQAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQV--------- 323
Cdd:cd19546     3 DEVPATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGDVHQRIldadaarpe 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 324 ---IPTSElqqfkwfwnsaESKDATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHA 400
Cdd:cd19546    83 lpvVPATE-----------EELPALLADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAA 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 401 YLARSNAQAPNwKAP-AQSILDFSLLQQK--------QGINQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQ-- 469
Cdd:cd19546   152 YGARREGRAPE-RAPlPLQFADYALWEREllageddrDSLIGDQIAYWRDALAGAPDELELP-------TDRPRPVLPsr 223
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 470 ---WLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDP-EFFDTVGYFTTMVAHRTQ 545
Cdd:cd19546   224 ragAVPLRLDAEVHARLMEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEgDLEGMVGPFARPLALRTD 303
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 546 FSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGM--RADEGLLFDVFIHIHSNNalNGALKTPQgqnLPYRQILPE 623
Cdd:cd19546   304 LSGDPTFRELLGRVREAVREARRHQDVPFERLAELLALppSADRHPVFQVALDVRDDD--NDPWDAPE---LPGLRTSPV 378
                         410       420       430       440       450
                  ....*....|....*....|....*....|....*....|....*....|....*...
gi 1752645431 624 ---RDESMFGLHFEIME--NVIDGQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:cd19546   379 plgTEAMELDLSLALTErrNDDGDPDGLDGSLRYAADLFDRATAAALARRLVRVLEQV 436
DCL_NRPS cd19543
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ...
256-676 9.80e-32

DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380465 [Multi-domain]  Cd Length: 423  Bit Score: 128.09  E-value: 9.80e-32
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLT-LAQDFLWQAYSAFDfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSelQQFKW 334
Cdd:cd19543     3 PLSpMQEGMLFHSLLDPG-SGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFVWEGLGEPLQVVLKD--RKLPW 79
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 335 F---W---NSAESK---DATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARS 405
Cdd:cd19543    80 ReldLshlSEAEQEaelEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALG 159
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 406 NAQAPNwKAPAQSILDF-SLLQQKQGinQDHLNYWTNLLRGATKGLNLPVSEHElnAEKEKPPVQWLELKFAPEMHEKLL 484
Cdd:cd19543   160 EGQPPS-LPPVRPYRDYiAWLQRQDK--EAAEAYWREYLAGFEEPTPLPKELPA--DADGSYEPGEVSFELSAELTARLQ 234
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 485 AFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGR-TD-PEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTM 562
Cdd:cd19543   235 ELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRpAElPGIETMVGLFINTLPVRVRLDPDQTVLELLKDLQAQ 314
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 563 INTSMAYADIPINHIQN--ALGmradeGLLFD---VFihihSNNALNGALKTPQGQNLPyrQIlpeRDESMFG-LHFEIM 636
Cdd:cd19543   315 QLELREHEYVPLYEIQAwsEGK-----QALFDhllVF----ENYPVDESLEEEQDEDGL--RI---TDVSAEEqTNYPLT 380
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|
gi 1752645431 637 ENVIDGQhQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:cd19543   381 VVAIPGE-ELTIKLSYDAEVFDEATIERLLGHLRRVLEQV 419
PRK12316 PRK12316
peptide synthase; Provisional
250-665 4.84e-30

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 127.77  E-value: 4.84e-30
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  250 QSVDQAPLTLAQD---FLWQAYSAfdfSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPT 326
Cdd:PRK12316    45 SSAERDRLSYAQQrmwFLWQLEPQ---SGAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFPRGADDSLAQVPLD 121
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  327 SELQ-QFKWFWNSAES-KDATLASEASYK----FDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHA 400
Cdd:PRK12316   122 RPLEvEFEDCSGLPEAeQEARLRDEAQREslqpFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEFSRF 201
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  401 YLARSNAQAPNWKAPAQSILDFSLLQQK---QGINQDHLNYWTNLLRGATKGLNLPVsehelnaEKEKPPVQ-----WLE 472
Cdd:PRK12316   202 YSAYATGAEPGLPALPIQYADYALWQRSwleAGEQERQLEYWRAQLGEEHPVLELPT-------DHPRPAVPsyrgsRYE 274
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  473 LKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSF 552
Cdd:PRK12316   275 FSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVNTQVLRSVFDGRTRV 354
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  553 QSLLHNISTMINTSMAYADIPINHIQNALgmRADEGL----LFDVFIHIHSNNALNGALKTPQGQNLpyrQILPERDESM 628
Cdd:PRK12316   355 ATLLAGVKDTVLGAQAHQDLPFERLVEAL--KVERSLshspLFQVMYNHQPLVADIEALDTVAGLEF---GQLEWKSRTT 429
                          410       420       430
                   ....*....|....*....|....*....|....*..
gi 1752645431  629 fglHFEIMENVIDGQHQLSMIITYQAHRFPTATVQSI 665
Cdd:PRK12316   430 ---QFDLTLDTYEKGGRLHAALTYATDLFEARTVERM 463
C_PKS-NRPS cd19532
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ...
255-595 4.78e-29

Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380455 [Multi-domain]  Cd Length: 421  Bit Score: 120.25  E-value: 4.78e-29
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 255 APLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIF--NSANGQTYQQVIPTSELQqF 332
Cdd:cd19532     2 EPMSFGQSRFWFLQQYLEDPTTFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFftDPEDGEPMQGVLASSPLR-L 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 333 KWFWNSAESkDATLASEA--SYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYlarsnaQAP 410
Cdd:cd19532    81 EHVQISDEA-EVEEEFERlkNHVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAY------NGQ 153
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 411 NWKAPAQSILDFSLLQQKQ---GINQDHLNYWTNLLRGATKGL-NLPVSEHelnaeKEKPPVQ-----WLELKFAPEMHE 481
Cdd:cd19532   154 PLLPPPLQYLDFAARQRQDyesGALDEDLAYWKSEFSTLPEPLpLLPFAKV-----KSRPPLTrydthTAERRLDAALAA 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 482 KLLAFSRQHSSSIFTVlYTAIAHA-LQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNIS 560
Cdd:cd19532   229 RIKEASRKLRVTPFHF-YLAALQVlLARLLDVDDICIGIADANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADVLKETR 307
                         330       340       350
                  ....*....|....*....|....*....|....*..
gi 1752645431 561 TMINTSMAYADIPINHIQNALGMRADEGL--LFDVFI 595
Cdd:cd19532   308 DKAYAALAHSRVPFDVLLDELGVPRSATHspLFQVFI 344
DCL_NRPS-like cd19536
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ...
255-676 7.36e-26

DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380459 [Multi-domain]  Cd Length: 419  Bit Score: 110.62  E-value: 7.36e-26
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 255 APLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVI------PTSE 328
Cdd:cd19536     2 YPLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDGLGQPVQVVhrqaqvPVTE 81
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 329 LQQfkWFWNSAESK-DATLASEASYKFDLTRELPLRIRLIRNAK-GRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSn 406
Cdd:cd19536    82 LDL--TPLEEQLDPlRAYKEETKIRRFDLGRAPLVRAALVRKDErERFLLVISDHHSILDGWSLYLLVKEILAVYNQLL- 158
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 407 AQAPNWKAPAQSILDFSLLQQKQGINQDHLNYWTNLLRGATkGLNLPvsehELNAEKEKPPVQWLELKFAPEMHEKLLAF 486
Cdd:cd19536   159 EYKPLSLPPAQPYRDFVAHERASIQQAASERYWREYLAGAT-LATLP----ALSEAVGGGPEQDSELLVSVPLPVRSRSL 233
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 487 SRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRtdPEFFD----TVGYFTTMVAHRTQFSpSDSFQSLLHNISTM 562
Cdd:cd19536   234 AKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGR--SEETTgaerLLGLFLNTLPLRVTLS-EETVEDLLKRAQEQ 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 563 INTSMAYADIPINHIQNalgmRADEGLLFDV---FIHIHSNNALNGalktpqgqnlpyrqilPERDESMFG--LHFEIME 637
Cdd:cd19536   311 ELESLSHEQVPLADIQR----CSEGEPLFDSivnFRHFDLDFGLPE----------------WGSDEGMRRglLFSEFKS 370
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|....*
gi 1752645431 638 N------VIDGQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:cd19536   371 NydvnlsVLPKQDRLELKLAYNSQVLDEEQAQRLAAYYKSAIAEL 415
PRK12316 PRK12316
peptide synthase; Provisional
156-674 1.50e-25

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 113.51  E-value: 1.50e-25
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  156 DANSTKASEQSNQNYVSEIILEEFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLlNKHGIEIQFNDFFKSPSAADLAQ 235
Cdd:PRK12316  3542 DAALLQQDYVAPVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQVVSRA-RQAGIRFTPKDLFQHQTIQGLAR 3620
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  236 YALVKSAktekttlQSVDQAPLTLAQDFLwqaysafdfsPIYNLPFAVEFLEE--INEDVFF------------QAFTDI 301
Cdd:PRK12316  3621 VARVGGG-------VAVDQGPVSGETLLL----------PIQQQFFEEPVPERhhWNQSLLLkprealdaaaleAALQAL 3683
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  302 VERHAGLRTIFNSANGQTYQQVIPTSELQQFKWfwnSAESKDAT----LASEASYKFDLTRELPLRIRLIRNAKGRQTLS 377
Cdd:PRK12316  3684 VEHHDALRLRFVEDAGGWTAEHLPVELGGALLW---RAELDDAEelerLGEEAQRSLDLADGPLLRALLATLADGSQRLL 3760
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  378 FLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSLLQQ---KQGINQDHLNYWTNLLRGATKglNLPV 454
Cdd:PRK12316  3761 LVIHHLVVDGVSWRILLEDLQQAYQQLLQGEAPRLPAKTSSFKAWAERLQehaRGEALKAELAYWQEQLQGVSS--ELPC 3838
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  455 sEHELNAEKEKpPVQWLELKFAPEMHEKLLAFS-RQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPeFFD-- 531
Cdd:PRK12316  3839 -DHPQGALQNR-HAASVQTRLDRELTRRLLQQApAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGREDL-FADid 3915
                          410       420       430       440       450       460       470       480
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  532 ---TVGYFTTMVAHRtqFSPS----DSFQSLLHNISTMINTSMAYADIPI---NHIQNALGMRADEGLLFDVFIHIHSNN 601
Cdd:PRK12316  3916 lsrTVGWFTSLFPVR--LSPVedlgASIKAIKEQLRAIPNKGIGFGLLRYlgdEESRRTLAGLPVPRITFNYLGQFDGSF 3993
                          490       500       510       520       530       540       550
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1752645431  602 ALNGALKTPQGQNLPYRQilpeRDESMFGLHFEIMENVIDGqhQLSMIITYQAHRFPTATVQSICEKIKATLA 674
Cdd:PRK12316  3994 DEEMALFVPAGESAGAEQ----SPDAPLDNWLSLNGRVYGG--ELSLDWTFSREMFEEATIQRLADDYAAELT 4060
C_PKS-NRPS cd20483
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ...
256-582 2.84e-25

Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380471 [Multi-domain]  Cd Length: 430  Bit Score: 109.27  E-value: 2.84e-25
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQFKWF 335
Cdd:cd20483     3 PMSTFQRRLWFLHNFLEDKTFLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDFGEQQVLDDPSFHLIVID 82
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 336 WNSAESKDATL----ASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAY--LARSNAQA 409
Cdd:cd20483    83 LSEAADPEAALdqlvRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYdaLRAGRDLA 162
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 410 pNWKAPAQSILDFSLLQQK---QGINQDHLNYWTNLLRGA--TKGLnLPvsehelNAEKEKPPVQWLE-----LKFAPEM 479
Cdd:cd20483   163 -TVPPPPVQYIDFTLWHNAllqSPLVQPLLDFWKEKLEGIpdASKL-LP------FAKAERPPVKDYErstveATLDKEL 234
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 480 HEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNI 559
Cdd:cd20483   235 LARMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLEST 314
                         330       340
                  ....*....|....*....|...
gi 1752645431 560 STMINTSMAYADIPINHIQNALG 582
Cdd:cd20483   315 KTTCLEAYEHSAVPFDYIVDALD 337
starter-C_NRPS cd19533
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ...
256-597 2.77e-22

Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380456 [Multi-domain]  Cd Length: 419  Bit Score: 99.75  E-value: 2.77e-22
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 256 PLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQFkwF 335
Cdd:cd19533     3 PLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGEPYQWIDPYTPVPIR--H 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 336 WNSAESKDATLASEASYKFDLTRELPL------RIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQA 409
Cdd:cd19533    81 IDLSGDPDPEGAAQQWMQEDLRKPLPLdndplfRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALLKGRP 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 410 PnwkaPAQSILDFSLLQQKQginQDHL---------NYWTNLLRGATKglnlPVSEHElNAEKEKPPVQWLELKFAPEMH 480
Cdd:cd19533   161 A----PPAPFGSFLDLVEEE---QAYRqserferdrAFWTEQFEDLPE----PVSLAR-RAPGRSLAFLRRTAELPPELT 228
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 481 EKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNIS 560
Cdd:cd19533   229 RTLLEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVS 308
                         330       340       350
                  ....*....|....*....|....*....|....*..
gi 1752645431 561 TMINTSMAYADIPINHIQNALGMRADEGLLFDVFIHI 597
Cdd:cd19533   309 RELRSLLRHQRYRYEDLRRDLGLTGELHPLFGPTVNY 345
C_PKS-NRPS_PksJ-like cd20484
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ...
254-564 1.00e-20

Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380472 [Multi-domain]  Cd Length: 430  Bit Score: 95.46  E-value: 1.00e-20
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 254 QAPLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQFK 333
Cdd:cd20484     1 RSPLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGVPFQKIEPSKPLSFQE 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 334 WFWNSAESKD--ATLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPN 411
Cdd:cd20484    81 EDISSLKESEiiAYLREKAKEPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQPT 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 412 WKAPAQSILDF-----SLLQQKQGinQDHLNYWTNLLRGATKGLNLPvsehelnAEKEKPPVQwlelKFAPEMHEKLL-- 484
Cdd:cd20484   161 LASSPASYYDFvaweqDMLAGAEG--EEHRAYWKQQLSGTLPILELP-------ADRPRSSAP----SFEGQTYTRRLps 227
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 485 -------AFSRQHSSSIFTVL---YTAIAHALQQQgnlKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPSDSFQS 554
Cdd:cd20484   228 elsnqikSFARSQSINLSTVFlgiFKLLLHRYTGQ---EDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSD 304
                         330
                  ....*....|.
gi 1752645431 555 LLHNIS-TMIN 564
Cdd:cd20484   305 FIRKLQlTVLD 315
FUM14_C_NRPS-like cd19545
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ...
274-676 3.56e-19

Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380467 [Multi-domain]  Cd Length: 395  Bit Score: 90.05  E-value: 3.56e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 274 SPIYNLPFavEFLEEINEDVFFQAFTDIVERHAGLRT-IFNSANGQTYQQVIPTSELQqfkwfWNSAESKDATLASEASY 352
Cdd:cd19545    21 AYVGQRVF--ELPPDIDLARLQAAWEQVVQANPILRTrIVQSDSGGLLQVVVKESPIS-----WTESTSLDEYLEEDRAA 93
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 353 KFDLTRELpLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKaPAQSILDFSLLQQKQgin 432
Cdd:cd19545    94 PMGLGGPL-VRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEPVPQPPPFS-RFVKYLRQLDDEAAA--- 168
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 433 qdhlNYWTNLLRGA--TKGLNLPVSEHelnaekEKPPVQWLElkfapemHEKLLAFSRQHSSSIFTVLYTAIAHALQQQG 510
Cdd:cd19545   169 ----EFWRSYLAGLdpAVFPPLPSSRY------QPRPDATLE-------HSISLPSSASSGVTLATVLRAAWALVLSRYT 231
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 511 NLKDIVIGTSASGRTDP----EffDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQnALGMRAD 586
Cdd:cd19545   232 GSDDVVFGVTLSGRNAPvpgiE--QIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDMIPFEHTGLQNIR-RLGPDAR 308
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 587 EGLLFDVFIHIHSNNALNGALKTPQGqnlPYRQILPERDESMFGLHFEIMEnvidGQHQLSMIITYQAHRFPTATVQSIC 666
Cdd:cd19545   309 AACNFQTLLVVQPALPSSTSESLELG---IEEESEDLEDFSSYGLTLECQL----SGSGLRVRARYDSSVISEEQVERLL 381
                         410
                  ....*....|
gi 1752645431 667 EKIKATLAQI 676
Cdd:cd19545   382 DQFEHVLQQL 391
E_NRPS cd19534
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ...
277-539 5.38e-19

Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.


Pssm-ID: 380457 [Multi-domain]  Cd Length: 428  Bit Score: 90.00  E-value: 5.38e-19
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 277 YNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQtYQQVIPTSELQQFKWF-WNSAESKDAT----LASEAS 351
Cdd:cd19534    22 FNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRREDGG-WQQRIRGDVEELFRLEvVDLSSLAQAAaieaLAAEAQ 100
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 352 YKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQaPNWKAPAQSILDFSLLQQKQGI 431
Cdd:cd19534   101 SSLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQALAGE-PIPLPSKTSFQTWAELLAEYAQ 179
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 432 NQD---HLNYWTNLLRGATKGLNLPVSEHELNAEKEkppvqwlELKFAPEMHEKLL--AFSRQHsSSIFTVLYTAIAHAL 506
Cdd:cd19534   180 SPAlleELAYWRELPAADYWGLPKDPEQTYGDARTV-------SFTLDEEETEALLqeANAAYR-TEINDLLLAALALAF 251
                         250       260       270
                  ....*....|....*....|....*....|....*..
gi 1752645431 507 QQQGNLKDIVIGTSASGR----TDPEFFDTVGYFTTM 539
Cdd:cd19534   252 QDWTGRAPPAIFLEGHGReeidPGLDLSRTVGWFTSM 288
C_NRPS-like cd19537
Condensation family domain with an atypical active site motif; Condensation (C) domains of ...
264-676 4.55e-17

Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380460 [Multi-domain]  Cd Length: 395  Bit Score: 83.77  E-value: 4.55e-17
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 264 LWQAY------SAFdfspiyNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQfkwfwn 337
Cdd:cd19537    11 WWHKYqlstgtSSF------NVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYVPRDGGLRRSYSSSPPRVQ------ 78
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 338 saESKDATLASEASYKFDLTRELPLRIRLIRNakgrqTLSFLVHHMVIDEWSLNTIMADLAHAY-------LARSNAQAP 410
Cdd:cd19537    79 --RVDTLDVWKEINRPFDLEREDPIRVFISPD-----TLLVVMSHIICDLTTLQLLLREVSAAYngkllppVRREYLDST 151
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 411 NWKAPAqsildfsllqqkqgiNQDHLNYWTNLLRGATkGLNLPVSEHELNAEKEKppvqwLELKFAPEMHEKLLAFSRQH 490
Cdd:cd19537   152 AWSRPA---------------SPEDLDFWSEYLSGLP-LLNLPRRTSSKSYRGTS-----RVFQLPGSLYRSLLQFSTSS 210
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 491 SSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDPEFFDTVGYFTTMVAHRTQFSPS--DSFQSLLHNISTMINTSMA 568
Cdd:cd19537   211 GITLHQLALAAVALALQDLSDRTDIVLGAPYLNRTSEEDMETVGLFLEPLPIRIRFPSSsdASAADFLRAVRRSSQAALA 290
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 569 YAdIPINHIQNALGMRADeGL---LFDVFIHIHSNNALNGALktpqgqNLPYRQILPERDE-SMFGLHFEIMENVIDGqh 644
Cdd:cd19537   291 HA-IPWHQLLEHLGLPPD-SPnhpLFDVMVTFHDDRGVSLAL------PIPGVEPLYTWAEgAKFPLMFEFTALSDDS-- 360
                         410       420       430
                  ....*....|....*....|....*....|..
gi 1752645431 645 qLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:cd19537   361 -LLLRLEYDTDCFSEEEIDRIESLILAALELL 391
PRK12316 PRK12316
peptide synthase; Provisional
191-539 4.28e-16

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 83.08  E-value: 4.28e-16
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  191 HDDFFDFGGHSLLATRIIGNLlNKHGIEIQFNDFFKSPSAADLAQYALVKSAKTEKTTlQSVDQAPLTLAQD-FLWQAYS 269
Cdd:PRK12316  1039 DDNFFELGGDSIVSIQVVSRA-RQAGIQLSPRDLFQHQTIRSLALVAKAGQATAADQG-PASGEVALAPVQRwFFEQAIP 1116
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  270 AFDFspiYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANG---QTYQQVIPTSELQQfkwfwNSAESKDATL 346
Cdd:PRK12316  1117 QRQH---WNQSLLLQARQPLDPDRLGRALERLVAHHDALRLRFREEDGgwqQAYAAPQAGEVLWQ-----RQAASEEELL 1188
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  347 AS--EASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAY---LARSNAQAPNWKAPAQsild 421
Cdd:PRK12316  1189 ALceEAQRSLDLEQGPLLRALLVDMADGSQRLLLVIHHLVVDGVSWRILLEDLQRAYadlDADLPARTSSYQAWAR---- 1264
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  422 fsLLQQKQGINQDHLNYWTNLLRGATKGLNLPVSEHELNAEKEKPpvqwLELKFAPEMHEKLL-----AFSRQhsssIFT 496
Cdd:PRK12316  1265 --RLHEHAGARAEELDYWQAQLEDAPHELPCENPDGALENRHERK----LELRLDAERTRQLLqeapaAYRTQ----VND 1334
                          330       340       350       360
                   ....*....|....*....|....*....|....*....|....*....
gi 1752645431  497 VLYTAIAHALQQQGNLKDIVIGTSASGRTDpeFFD------TVGYFTTM 539
Cdd:PRK12316  1335 LLLTALARVTCRWSGQASVLVQLEGHGRED--LFEdidlsrTVGWFTSL 1381
PRK12467 PRK12467
peptide synthase; Provisional
181-551 6.26e-15

peptide synthase; Provisional


Pssm-ID: 237108 [Multi-domain]  Cd Length: 3956  Bit Score: 79.05  E-value: 6.26e-15
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  181 NTLAEPEMSQHDDFFDFGGHSLLATRIIGNLlNKHGIEIQFNDFFKSPSAADLAQYALVKSAktekttLQSVDQAPLTla 260
Cdd:PRK12467  2108 DVLGLEQVGLHDNFFELGGDSIISIQVVSRA-RQAGIRFTPKDLFQHQTVQSLAAVAQEGDG------TVSIDQGPVT-- 2178
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  261 qdflwqaysafDFSPIynLPFAVEFLEEI-------NEDVFFQ------------AFTDIVERHAGLRTIFNSANGQTYQ 321
Cdd:PRK12467  2179 -----------GDLPL--LPIQQMFFADDiperhhwNQSVLLEprealdaelleaALQALLVHHDALRLGFVQEDGGWSA 2245
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  322 QVIPTSELQQfKWFWNSAESKDA---TLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLA 398
Cdd:PRK12467  2246 MHRAPEQERR-PLLWQVVVADKEeleALCEQAQRSLDLEEGPLLRAVLATLPDGSQRLLLVIHHLVVDGVSWRILLEDLQ 2324
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  399 HAYLARSNAQAPNWKAPAQSILDFS-LLQQ--KQGINQDHLNYWTNLLRGATKGLNLPVSEHELNAEKEKPPVQWLElkf 475
Cdd:PRK12467  2325 TAYRQLQGGQPVKLPAKTSAFKAWAeRLQTyaASAALADELGYWQAQLQGASTELPCDHPQGGLQRRHAASVTTHLD--- 2401
                          330       340       350       360       370       380       390       400
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  476 aPEMHEKLLAFS-RQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGRTDpeFFD------TVGYFTTMVAHRtqFSP 548
Cdd:PRK12467  2402 -SEWTRRLLQEApAAYRTQVNDLLLTALARVIARWTGQASTLIQLEGHGRED--LFDeidltrTVGWFTSLYPVK--LSP 2476

                   ...
gi 1752645431  549 SDS 551
Cdd:PRK12467  2477 TAS 2479
PRK12316 PRK12316
peptide synthase; Provisional
294-676 9.40e-14

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 75.38  E-value: 9.40e-14
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  294 FFQAFTDIVERHAGLRTIF--NSANGQTYQQVIPTSELQQFKWFWNSAESKDATL----ASEASYKFDLTRELPLRIRLI 367
Cdd:PRK12316  4141 FRAAWQAALDRHDVLRSGFvwQGELGRPLQVVHKQVSLPFAELDWRGRADLQAALdalaAAERERGFDLQRAPLLRLVLV 4220
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  368 RNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQapnwkaPAQSILDFSLLQQKQGINQDHlNYWTNLLRgat 447
Cdd:PRK12316  4221 RTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERYSGRPPAQ------PGGRYRDYIAWLQRQDAAASE-AFWREQLA--- 4290
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  448 kGLNLPVSEHELNAEKEKPPVQW---LELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASGR 524
Cdd:PRK12316  4291 -ALDEPTRLAQAIARADLRSANGygeHVRELDATATARLREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGR 4369
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  525 TD--PEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQNALGMRADEglLFDVfIHIHSNNA 602
Cdd:PRK12316  4370 PAelPGIEGQIGLFINTLPVIATPRAQQSVVEWLQQVQRQNLALREHEHTPLYEIQRWAGQGGEA--LFDS-LLVFENYP 4446
                          330       340       350       360       370       380       390
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1752645431  603 LNGALKTPQGQNLPYRQILpERDESMFGLHFeimenVIDGQHQLSMIITYQAHRFPTATVQSICEKIKATLAQI 676
Cdd:PRK12316  4447 VSEALQQGAPGGLRFGEVT-NHEQTNYPLTL-----AVGLGETLSLQFSYDRGHFDAATIERLARHLTNLLEAM 4514
PRK05691 PRK05691
peptide synthase; Validated
164-538 1.99e-13

peptide synthase; Validated


Pssm-ID: 235564 [Multi-domain]  Cd Length: 4334  Bit Score: 74.43  E-value: 1.99e-13
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  164 EQSNQNYVS-EIILEE-----FRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLlNKHGIEIQFNDFFKSPSAADLAQYA 237
Cdd:PRK05691  2697 ELNRQAYQApRSELEQqlaqiWREVLNVERVGLGDNFFELGGDSILSIQVVSRA-RQLGIHFSPRDLFQHQTVQTLAAVA 2775
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  238 L-VKSAKTEKTTLQSvdQAPLTLAQDFLwqaysaFDfSPI-----YNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTI 311
Cdd:PRK05691  2776 ThSEAAQAEQGPLQG--ASGLTPIQHWF------FD-SPVpqpqhWNQALLLEPRQALDPALLEQALQALVEHHDALRLR 2846
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  312 FNSANGQTYQQVIPTSElQQFKWFWNSAESKDAT-LASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSL 390
Cdd:PRK05691  2847 FSQADGRWQAEYRAVTA-QELLWQVTVADFAECAaLFADAQRSLDLQQGPLLRALLVDGPQGQQRLLLAIHHLVVDGVSW 2925
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  391 NTIMADLAHAYLARSNAQAPNWKAPAQSILDFSL-LQQKQGIN--QDHLNYWTNLLRGATKglNLPVseHELNAEKEKPP 467
Cdd:PRK05691  2926 RVLLEDLQALYRQLSAGAEPALPAKTSAFRDWAArLQAYAGSEslREELGWWQAQLGGPRA--ELPC--DRPQGGNLNRH 3001
                          330       340       350       360       370       380       390
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1752645431  468 VQWLELKFAPEMHEKLLafsRQHSSSIFT----VLYTAIAHALQQQGNLKDIVIGTSASGRT----DPEFFDTVGYFTT 538
Cdd:PRK05691  3002 AQTVSVRLDAERTRQLL---QQAPAAYRTqvndLLLTALARVLCRWSGQPSVLVQLEGHGREalfdDIDLTRSVGWFTS 3077
PRK05691 PRK05691
peptide synthase; Validated
294-578 3.92e-12

peptide synthase; Validated


Pssm-ID: 235564 [Multi-domain]  Cd Length: 4334  Bit Score: 70.20  E-value: 3.92e-12
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  294 FFQAFTDIVERHAGLRTIFNSANGQTYQQVIPT---SELQQFKWFWNSAESKD----ATLASEASYKFDLTRELPLRIRL 366
Cdd:PRK05691  3297 FAQAWQAVVARHEALRASFSWNAGETMLQVIHKpgrTPIDYLDWRGLPEDGQEqrlqALHKQEREAGFDLLNQPPFHLRL 3376
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  367 IRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWkAPAQSILDFSLLQQKQGINQDHlNYWTNLLRGA 446
Cdd:PRK05691  3377 IRVDEARYWFMMSNHHILIDAWCRSLLMNDFFEIYTALGEGREAQL-PVPPRYRDYIGWLQRQDLAQAR-QWWQDNLRGF 3454
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  447 TKGLNLPVSE---HELNAEKEKPPVQWLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIVIGTSASG 523
Cdd:PRK05691  3455 ERPTPIPSDRpflREHAGDSGGMVVGDCYTRLDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAG 3534
                          250       260       270       280       290       300
                   ....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  524 R--TDPEFFDTVGYFTTMVAHRTQFSPSDSFQSLLHNISTMINTSMA---YADIPINHIQ 578
Cdd:PRK05691  3535 RpvSMPQMQRTVGLFINSIALRVQLPAAGQRCSVRQWLQGLLDSNMElreYEYLPLVAIQ 3594
beta-lac_NRPS cd19547
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ...
283-595 1.19e-11

Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.


Pssm-ID: 380469 [Multi-domain]  Cd Length: 422  Bit Score: 67.34  E-value: 1.19e-11
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 283 VEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIpTSELQQ----FKWFWNS----AESKDATLASEASYKF 354
Cdd:cd19547    30 LELVGGTDEDVLREAWRRVADRYEILRTGFTWRDRAEPLQYV-RDDLAPpwalLDWSGEDpdrrAELLERLLADDRAAGL 108
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 355 DLTrELPL-RIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKaPAQSILDF-SLLQQKQGIN 432
Cdd:cd19547   109 SLA-DCPLyRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEELAHGREPQLS-PCRPYRDYvRWIRARTAQS 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 433 QDHLNYWTNLLRGATKGlnlPVSEHELNAEKEKPPVQWlelKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNL 512
Cdd:cd19547   187 EESERFWREYLRDLTPS---PFSTAPADREGEFDTVVH---EFPEQLTRLVNEAARGYGVTTNAISQAAWSMLLALQTGA 260
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 513 KDIVIGTSASGRTdPEFFDT---VGYFTTMVAHRTQFSPSDSFQSLLHNISTMINTSMAYADIPINHIQN-ALGMRADEG 588
Cdd:cd19547   261 RDVVHGLTIAGRP-PELEGSehmVGIFINTIPLRIRLDPDQTVTGLLETIHRDLATTAAHGHVPLAQIKSwASGERLSGG 339

                  ....*..
gi 1752645431 589 LLFDVFI 595
Cdd:cd19547   340 RVFDNLV 346
PRK12316 PRK12316
peptide synthase; Provisional
286-524 3.77e-08

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 57.27  E-value: 3.77e-08
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  286 LEEINEDVFFQAFTDIVERHAGLRTIFNSANG--QTYQQVIPTSELQQFKWFWNSAESKDATLASEASYK----FDLTRE 359
Cdd:PRK12316  1587 VQGLDPDRFRAAWQATVDRHEILRSGFLWQDGleQPLQVIHKQVELPFAELDWRGREDLGQALDALAQAErqkgFDLTRA 1666
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  360 LPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLahayLARSNAQAPnwKAPAQSILDFS--LLQQKQGINQdhlN 437
Cdd:PRK12316  1667 PLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEV----LQRYAGQPV--AAPGGRYRDYIawLQRQDAAASE---A 1737
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  438 YWTNLLrgatKGLNLPVS-EHELNAEKEKPPVQWLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDIV 516
Cdd:PRK12316  1738 FWKEQL----AALEEPTRlAQAARTEDGQVGYGDHQQLLDPAQTRALAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVA 1813

                   ....*...
gi 1752645431  517 IGTSASGR 524
Cdd:PRK12316  1814 FGATVAGR 1821
PP-binding pfam00550
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ...
169-232 3.99e-08

Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.


Pssm-ID: 425746 [Multi-domain]  Cd Length: 62  Bit Score: 50.25  E-value: 3.99e-08
                          10        20        30        40        50        60
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1752645431 169 NYVSEIILEEFRntLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAAD 232
Cdd:pfam00550   1 ERLRELLAEVLG--VPAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
AcpP COG0236
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ...
162-236 1.36e-07

Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis


Pssm-ID: 440006 [Multi-domain]  Cd Length: 80  Bit Score: 49.47  E-value: 1.36e-07
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1752645431 162 ASEQSNQNYVSEIILEEFRntLAEPEMSQHDDFF-DFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQY 236
Cdd:COG0236     1 MPREELEERLAEIIAEVLG--VDPEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADY 74
entF PRK10252
enterobactin non-ribosomal peptide synthetase EntF;
256-410 1.52e-07

enterobactin non-ribosomal peptide synthetase EntF;


Pssm-ID: 236668 [Multi-domain]  Cd Length: 1296  Bit Score: 55.05  E-value: 1.52e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  256 PLTLAQDFLWQAYSAFDFSPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIP--TSELQQFK 333
Cdd:PRK10252     9 PLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGEVWQWVDPalTFPLPEII 88
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  334 WFWNSAESKDATLA---SEASYKFDLTRELPL-RIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQA 409
Cdd:PRK10252    89 DLRTQPDPHAAAQAlmqADLQQDLRVDSGKPLvFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYCAWLRGEP 168

                   .
gi 1752645431  410 P 410
Cdd:PRK10252   169 T 169
alpha_am_amid TIGR03443
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ...
168-234 1.08e-06

L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.


Pssm-ID: 274582 [Multi-domain]  Cd Length: 1389  Bit Score: 52.37  E-value: 1.08e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  168 QNYVSEIILEEFRNTLAE-------------PEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLA 234
Cdd:TIGR03443  835 KNRSASAADEEFTETEREirdlwlellpnrpATISPDDSFFDLGGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFA 914
PRK12467 PRK12467
peptide synthase; Provisional
294-524 5.06e-06

peptide synthase; Provisional


Pssm-ID: 237108 [Multi-domain]  Cd Length: 3956  Bit Score: 50.16  E-value: 5.06e-06
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  294 FFQAFTDIVERHAGLRTIFNSANGQT------YQQV-IPTSELQqfkwfWNS----AESKDATLASEASYKFDLTRELPL 362
Cdd:PRK12467  2685 FRTAWQAVIDRHEILRSGFLWDGELEeplqvvYKQArLPFSRLD-----WRDradlEQALDALAAADRQQGFDLLSAPLL 2759
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  363 RIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAqapnwkAPAQSILDFSLLQQKQGiNQDHLNYWTNL 442
Cdd:PRK12467  2760 RLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQRYFGQPPP------AREGRYRDYIAWLQAQD-AEASEAFWKEQ 2832
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  443 LrgatkglnLPVSEHELNAEKEKP-PVQWLE------LKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAHALQQQGNLKDI 515
Cdd:PRK12467  2833 L--------AALEEPTRLARALYPaPAEAVAghgahyLHLDATQTRQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTV 2904

                   ....*....
gi 1752645431  516 VIGTSASGR 524
Cdd:PRK12467  2905 CFGATVAGR 2913
PRK12316 PRK12316
peptide synthase; Provisional
179-237 8.83e-06

peptide synthase; Provisional


Pssm-ID: 237054 [Multi-domain]  Cd Length: 5163  Bit Score: 49.57  E-value: 8.83e-06
                           10        20        30        40        50
                   ....*....|....*....|....*....|....*....|....*....|....*....
gi 1752645431  179 FRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQYA 237
Cdd:PRK12316  5081 WAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELA 5139
Cyc_NRPS cd19535
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ...
296-401 1.75e-05

Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.


Pssm-ID: 380458 [Multi-domain]  Cd Length: 423  Bit Score: 47.48  E-value: 1.75e-05
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431 296 QAFTDIVERHAGLRTIFNSaNGQtyQQVIPTSELQQFKWFW---NSAESKDATLA---SEAS-YKFDLTRELPLRIRLIR 368
Cdd:cd19535    44 RAWNKLIARHPMLRAVFLD-DGT--QQILPEVPWYGITVHDlrgLSEEEAEAALEelrERLShRVLDVERGPLFDIRLSL 120
                          90       100       110
                  ....*....|....*....|....*....|...
gi 1752645431 369 NAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAY 401
Cdd:cd19535   121 LPEGRTRLHLSIDLLVADALSLQILLRELAALY 153
AcpA COG3433
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ...
172-236 4.17e-05

Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 442659 [Multi-domain]  Cd Length: 295  Bit Score: 45.90  E-value: 4.17e-05
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1752645431 172 SEIILEEFRNTLAE------PEMSQHDDFFDFGGHSLLATRIIgNLLNKHGIEIQFNDFFKSPSAADLAQY 236
Cdd:COG3433   217 TALTEEELRADVAEllgvdpEEIDPDDNLFDLGLDSIRLMQLV-ERWRKAGLDVSFADLAEHPTLAAWWAL 286
EntF COG1020
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ...
191-512 1.10e-04

EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 440643 [Multi-domain]  Cd Length: 1329  Bit Score: 45.62  E-value: 1.10e-04
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  191 HDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQYALVKSAKTEKTTLQSVDQAPLTLAQDFLWQAYSA 270
Cdd:COG1020   1006 DDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLA 1085
                           90       100       110       120       130       140       150       160
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  271 FDF--SPIYNLPFAVEFLEEINEDVFFQAFTDIVERHAGLRTIFNSANGQTYQQVIPTSELQQFKWFWNSAES----KDA 344
Cdd:COG1020   1086 LLLllALLALLALLLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLaaaaAAA 1165
                          170       180       190       200       210       220       230       240
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  345 TLASEASYKFDLTRELPLRIRLIRNAKGRQTLSFLVHHMVIDEWSLNTIMADLAHAYLARSNAQAPNWKAPAQSILDFSL 424
Cdd:COG1020   1166 ELLAAAALLLLLALLLLALLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAA 1245
                          250       260       270       280       290       300       310       320
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1752645431  425 LQQKQGINQDHLNYWTNLLRGATKGLNLPVSEHELNAekekPPVQWLELKFAPEMHEKLLAFSRQHSSSIFTVLYTAIAH 504
Cdd:COG1020   1246 LLALAALAALAAALLALALALLALALLLLALALLLPA----LARARAARTARALALLLLLALLLLLALALALLLLLLLLL 1321

                   ....*...
gi 1752645431  505 ALQQQGNL 512
Cdd:COG1020   1322 ALLLLALL 1329
PRK12467 PRK12467
peptide synthase; Provisional
168-236 3.76e-04

peptide synthase; Provisional


Pssm-ID: 237108 [Multi-domain]  Cd Length: 3956  Bit Score: 44.00  E-value: 3.76e-04
                           10        20        30        40        50        60
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1752645431  168 QNYVSEIILEEFRNTLAEPEMSQHDDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQY 236
Cdd:PRK12467  3603 RSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPTIAELAGY 3671
entF PRK10252
enterobactin non-ribosomal peptide synthetase EntF;
192-236 4.81e-03

enterobactin non-ribosomal peptide synthetase EntF;


Pssm-ID: 236668 [Multi-domain]  Cd Length: 1296  Bit Score: 40.41  E-value: 4.81e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....*
gi 1752645431  192 DDFFDFGGHSLLATRIIGNLLNKHGIEIQFNDFFKSPSAADLAQY 236
Cdd:PRK10252  1000 ADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATL 1044
PKS_PP smart00823
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ...
194-236 9.29e-03

Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.


Pssm-ID: 214834 [Multi-domain]  Cd Length: 86  Bit Score: 35.69  E-value: 9.29e-03
                           10        20        30        40
                   ....*....|....*....|....*....|....*....|....
gi 1752645431  194 FFDFGGHSLLATRIIgNLLNKH-GIEIQFNDFFKSPSAADLAQY 236
Cdd:smart00823  39 FRDLGLDSLMAVELR-NRLEAAtGLRLPATLVFDHPTPAALAEH 81
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH